"Drug Carriers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
| Descriptor ID |
D004337
|
| MeSH Number(s) |
D26.255.260 E02.319.300.380
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Carriers".
Below are MeSH descriptors whose meaning is more specific than "Drug Carriers".
This graph shows the total number of publications written about "Drug Carriers" by people in this website by year, and whether "Drug Carriers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 2 | 3 |
| 2010 | 5 | 1 | 6 |
| 2011 | 2 | 0 | 2 |
| 2012 | 3 | 2 | 5 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 2 | 5 |
| 2015 | 4 | 3 | 7 |
| 2016 | 2 | 1 | 3 |
| 2017 | 2 | 4 | 6 |
| 2018 | 4 | 0 | 4 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Carriers" by people in Profiles.
-
In vivo characterization of carbon dots-bone interactions: toward the development of bone-specific nanocarriers for drug delivery. Drug Deliv. 2021 Dec; 28(1):1281-1289.
-
Harnessing molecular recognition for localized drug delivery. Adv Drug Deliv Rev. 2021 03; 170:238-260.
-
Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Mol Pharm. 2020 07 06; 17(7):2232-2244.
-
Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy. Sci Adv. 2019 08; 5(8):eaaw6081.
-
p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts. Sci Rep. 2019 03 18; 9(1):4762.
-
Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins. Small. 2018 12; 14(50):e1803601.
-
Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines. Biosci Rep. 2018 10 31; 38(5).
-
Preparation, Characterization, and Formulation Development of Drug-Drug Protic Ionic Liquids of Diphenhydramine with Ibuprofen and Naproxen. Mol Pharm. 2018 09 04; 15(9):4190-4201.
-
A novel strategy for in vivo angiogenesis and osteogenesis: magnetic micro-movement in a bone scaffold. Artif Cells Nanomed Biotechnol. 2018; 46(sup2):636-645.
-
Carbon dots: promising biomaterials for bone-specific imaging and drug delivery. Nanoscale. 2017 Nov 16; 9(44):17533-17543.